VELCADE 3.5 MG
bortézomib
Public price
5.855,00 MAD
Active substance
bortézomib
Laboratory
MAPHAR
What is this medicine?
VELCADE 3.5 MG contains bortézomib. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
bortézomib, Poudre pour solution injectable, 3.5 MG, Flacon de 10 ml
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Princeps
Laboratory
MAPHAR
Hospital price
5.615,00 MAD
Strength
3.5 MG
Form
Poudre pour solution injectable
Presentation
Flacon de 10 ml
ATC code
L01XX32
Type
Princeps
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 5.855,00 MAD
Available presentations and strengths
Medicines with the same active substance
CYTOMIB
3,5 MG · BOITE DE 1 FLACON DE 10 ML
3,31 MAD
BORT SPAL 2
2 MG · BOITE DE 1 FLACON
3,38 MAD
VEELBORE
3,5 MG · BOITE DE 1
3,65 MAD
MYBORTE
3,5 MG · BOITE DE 1 FLACON
4,77 MAD
BORT SPAL
3.5 MG · BOITE DE 1 FLACON
5,62 MAD
BORTEA
3.5 MG · BOITE D'UN FLACON
5,62 MAD
CYTOMIB 3.5 MG
3.5 MG · Boite de 1 flacon de 10 ML
3.306,00 MAD
BORT SPAL 2 MG
2 MG · Boite de 1 flacon
3.381,00 MAD
BORT SPAL 2 MG
2 MG · Poudre pour solution injectable
3.381,00 MAD
VEELBORE 3.5 MG
3.5 MG · Boite de un flacon de 8 ML
3.650,00 MAD
MYBORTE 3.5 MG
3.5 MG · Boite d'un flacon
4.774,00 MAD
BORT SPAL 3.5 MG
3.5 MG · 1 flacon
5.617,00 MAD